MARCI JOHNSON: Open Payments
NPI 1619521820 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 42 payments from 14 companies in 2025. Trend: 2023 $718 · 2024 $452 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $212 |
| Merck Sharp & Dohme LLC | 8 | $165 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Kestra Medical Technology Services, Inc. | 2 | $60 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Medtronic, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $22 |
Products named: CAMZYOS, VERQUVO, LEQVIO, Kerendia, Assure WCD, ELIQUIS, INSPIRE, MYCARELINK.
Industry payments across GA — which companies pay providers there.
